Quantification of nitric oxide and cytokines in rabbit aqueous humor after neodymium: YAG laser capsulotomy

Ophthalmic Research

Volumn 32, Issue 2-3, 2000, Pages 106-109

  Er, Hamdi ^a,b   Gündüz, Abuzer ^a   Çiǧli, Ahmet ^a   Turkoz, Yusuf ^a   Cekmen, Mustafa ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aqueous humor; Cytokines; Neodymium:Yag capsulotomy; Nitric oxide; Ocular inflammation

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CAPSULOTOMY; CONTROLLED STUDY; GENERAL SURGERY; LASER SURGERY; NEODYMIUM LASER; NONHUMAN; PHACOEMULSIFICATION; PRIORITY JOURNAL; RABBIT; TOPICAL ANESTHESIA;

EID: 0343091296     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055598     Document Type: Article

References (30)

1. Moisseiev J, Bartow E, Schochat A, Blumenthal M: Long-term study of the prevalence of capsular opacification following extracapsular cataract extraction. J Cataract Refract Surg 1989;15:531-533.
2. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hogatt JP, Kostick AM: Posterior capsule opacification. Surv Ophthalmol 1992;37:73-116.
3. Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993;54:171-178.
4. Nishi O, Nishi K, Ohmoto Y: Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation. Br J Ophthalmol 1994;78:917-920.
5. Amples JR, Boney RS, Rosenbaum JT: Ocular inflammatory effects of intravitreally injected interleukin-2. Curr Eye Res 1993;12:649-654.
6. Wong GG, Clark SC: Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1989;9:137-139.
7. Beutler B, Cerami A: The biology of cachectin/ TNF: A primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
8. Hoekzema R, Murray PI, van Haren MAC, Helle M, Kijlstra A: Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1991;32:83-95.
9. Katayama T: The effect of interleukin-1 on ocular inflammation in rabbit ocular tissue. Acta Soc Ophthalmol Jpn 1991;95:635-643.
10. Orpana AK, Avela K, Ranta V, Viinikka L, Ylikorkala O: The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia. Am J Obstet Gynecol 1996; 174:1056-1060.
11. Ulbig MW, McHugh DA, McNaught AI, Hamilton AM: Clinical comparison of semiconductor diode versus neodymium:YAG non-contact cyclo photocoagulation. Br J Ophthalmol 1995; 79:569-574.
12. Simşek S, Ertürk H, Demirok A, Cinal Y, Yaşar T, Karadenizli C: The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy. Eur J Ophthalmol 1998;8:167-172.
13. Kijlstra A: The role of cytokines in ocular inflammation. Br J Ophthalmol 1994;78:885-886.
14. Bazan NG, de Abreu MT, Bazan HE, Belfort R Jr: Arachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: Therapeutic implications in uveitis. Int Ophthalmol 1990;14:335-344.
15. Oslwald P, Goldstein IM, Pachnanda A, Roth S: Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 1995;36:2396-2403.
16. Wang ZY, Hakanson R: Role of nitric oxide (NO) in ocular inflammation. Br J Pharmacol 1995;116:2447-2450.
17. Defrawy SR: Nitric oxide: A unique biologic mediator. Can J Ophthalmol 1997;32:12-16.
18. Er H, Turkoz Y, Ozerol IH, Uzmez E: Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits. Eur J Ophthalmol 1998;8:137-141.
19. Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y: The role of nitric oxide synthase in endotoxin-induced uveitis: Effects of NG-nitro-L-arginine. Invest Ophthalmol Vis Sci 1994;35:3673-3679.
20. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N: Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1996;37:826-832.
21. Mulligan MS, Moncada S, Ward PA: Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992;107:1159-1162.
22. Oppenheim JJ, Ruscetti FW, Faltynek C: Cytokines; in Stites DP, Terr AI (eds): Basic Human Immunology. East Norwalk, Appleton & Lange, 1991, pp 78-100.
23. Miyake K, Mibu H, Horiguchi M, Shirasawa E: Inflammatory mediators in postoperative aphakic and pseudophakic baboon eyes. Arch Ophthalmol 1990;108:1764-1767.
24. BenEzra D, Maftzir G, Kalichman I, Barak V: Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol 1993;115: 26-30.
25. Bharracherjee P, Henderson B: Inflammatory responses of intraoculary injected IL-1. Curr Eye Res 1987;6:929-934.
26. Palexas GN, Sussman G, Welsh NH: Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol 1992;11:173-175.
27. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz M: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144-147.
28. Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT: IL-6/IFN-Β-2 as a circulating hormone: Induction by cytokine administration in humans. J Immunol 1989;142:1542-1547.
29. Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P: Role of interleukin 6 in the inflammatory response after cataract surgery. Arch Ophthalmol 1991;109:1681-1683.
30. Planck SR, Dang TT, Graves D, Tara D, Ansel JC, Rosenbaum JT: Retinal pigment epithelial cell secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci 1992;33: 78-82.